Of genes examined in relation to risk of invasive ovarian cancer and risk of invasive serous ovarian cancer, only global variation in the MSL1 and PRPF31 genes was associated at p<0.05. The gene discussed is PRPF31; the disease is ovarian serous adenocarcinoma.